Unfavorable signs in patients with chronic myelocytic leukemia.
D000782:Aneuploidy; D001491:Basophils; D001792:Blood Platelets / Q000473:pathology; D002471:Cell Transformation, Neoplastic; D002648:Child; D004796:Clinical Enzyme Tests; D003582:Cytogenetics; D004802:Eosinophilia / Q000150:complications; D005319:Fetal Hemoglobin; D005334:Fever / Q000150:complications; D006402:Hematologic Diseases / Q000150:complications; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications / Q000175:diagnosis* / Q000235:genetics / Q000401:mortality; D007958:Leukocyte Count; D008206:Lymphatic Diseases / Q000150:complications; D009113:Muramidase / Q000652:urine; D055728:Primary Myelofibrosis / Q000150:complications; D011379:Prognosis; D012877:Skin Manifestations; D013922:Thrombocytosis / Q000150:complications; D014805:Vitamin B 12 / Q000097:blood
D005319:Fetal Hemoglobin; D009113:Muramidase; D014805:Vitamin B 12